Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | STAT3 | P40763 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2534645 | 1.00 | LMNA (0.59) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL333126 | 0.82 | LMNA (0.66) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL114630 | 0.82 | LMNA (0.66) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL10968270 | 0.82 | LMNA (0.66) | LMNACYP3A4ALOX15STAT3MEN1 | |
| Hydrogen Sulfide SCHEMBL19357598 | 0.81 | LMNA (0.63) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL31545085 | 0.78 | LMNA (0.70) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL24956789 | 0.75 | LMNA (0.66) | LMNACYP3A4ALOX15STAT3MEN1 | |
| Alpha-Terpineol SCHEMBL901351 | 0.75 | LMNA (1.00) | LMNACYP3A4ALOX15STAT3MEN1 | |
| SCHEMBL5170826 | 0.75 | LMNA (0.66) | LMNACYP3A4ALOX15STAT3MEN1 | |
| Alpha-Terpineol SCHEMBL980991 | 0.75 | LMNA (1.00) | LMNACYP3A4ALOX15STAT3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596192-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| WO-2018169531-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |